Tekla Life Sciences Inves...

NYSE: HQL · Real-Time Price · USD
12.98
0.28 (2.20%)
At close: May 02, 2025, 3:59 PM
13.01
0.19%
After-hours: May 02, 2025, 04:05 PM EDT

Tekla Life Sciences Investors Statistics

Share Statistics

Tekla Life Sciences Investors has - shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding n/a
Shares Change (YoY) 0%
Shares Change (QoQ) 0%
Owned by Institutions (%) 33.54%
Shares Floating n/a
Failed to Deliver (FTD) Shares 138
FTD / Avg. Volume 0.1%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

PE Ratio 0
Forward PE n/a
PS Ratio 0
Forward PS n/a
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tekla Life Sciences Investors.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio 0
Quick Ratio 0
Debt / Equity 0
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count undefined
Asset Turnover 0.19
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -5.56% in the last 52 weeks. The beta is 0.77, so Tekla Life Sciences Investors's price volatility has been higher than the market average.

Beta 0.77
52-Week Price Change -5.56%
50-Day Moving Average 12.66
200-Day Moving Average 14.11
Relative Strength Index (RSI) 57.24
Average Volume (20 Days) 135,319

Income Statement

In the last 12 months, Tekla Life Sciences Investors had revenue of 86.69M and earned 85.3M in profits. Earnings per share was 0.

Revenue 86.69M
Gross Profit 86.69M
Operating Income 85.3M
Net Income 85.3M
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) 0
Full Income Statement

Balance Sheet

The company has 1 in cash and 0 in debt, giving a net cash position of 1.

Cash & Cash Equivalents 1
Total Debt n/a
Net Cash n/a
Retained Earnings 44.13M
Total Assets 460.58M
Working Capital 281.61K
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share 0
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of 98.4% and 98.4%.

Gross Margin 100%
Operating Margin 98.4%
Pretax Margin 98.4%
Profit Margin 98.4%
EBITDA Margin n/a
EBIT Margin 98.4%
FCF Margin n/a

Dividends & Yields

HQL pays an annual dividend of $2.33, which amounts to a dividend yield of 14.01%.

Dividend Per Share $2.33
Dividend Yield 14.01%
Dividend Growth (YoY) 20.51%
Payout Ratio 76.64%
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for HQL.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 244.13
Piotroski F-Score 3